Author: The Carcinoid Cancer Foundation (CCF)
![university of pennsylvania continuing medical education](https://i0.wp.com/www.carcinoid.org/wp-content/uploads/2011/09/university-of-pennsylvania-continuing-medical-education.jpg?resize=300%2C99&ssl=1)
New Feature for Medical Professionals on Carcinoid Cancer Foundation Website
The Carcinoid Cancer Foundation is pleased to announce that a new feature for the medical community has been added to its website, www.carcinoid.org. The section is entitled Continuing Medical Education (CME). Upcoming events include:
- The Penn
![caduceus2](https://i0.wp.com/www.carcinoid.org/wp-content/uploads/2011/08/caduceus2.jpeg?resize=266%2C190&ssl=1)
Nominate a Hero
“A hero is someone who has given his or her life to something bigger than oneself.” Joseph Campbell
The Carcinoid Cancer Foundation would like to recognize the healthcare heroes and heroines who change the lives of patients and their loved…
READ MORE![Richard R.P. Warner, MD2](https://i0.wp.com/www.carcinoid.org/wp-content/uploads/2011/08/richard-r-p-warner-md21-scaled.jpg?resize=300%2C300&ssl=1)
Pancreatic Neuroendocrine Tumors: A Rare Cancer
From your next door neighbor to Steve Jobs, co-founder of Apple who just announced that he is stepping down as CEO of the company, pancreatic neuroendocrine tumors (pNETs) affect less than 1 person in 100,000 in the United States. This rare cancer is often…
READ MORE![steve jobs bloomberg news](https://i0.wp.com/www.carcinoid.org/wp-content/uploads/2011/08/steve-jobs-bloomberg-news.jpg?resize=262%2C174&ssl=1)
Breaking News: Pancreatic NET Cancer Patient Steve Jobs Steps Down as CEO of Apple
On August 24, 2011, Steve Jobs, CEO of Apple, announced that he was stepping down from his position. In his letter to the Apple Board of Directors and the Apple Community, Mr. Jobs wrote, “I have always said if there ever came a day when I could no longer meet…
READ MORE![Cranes](https://i0.wp.com/www.carcinoid.org/wp-content/uploads/2011/08/cranes.jpg?resize=300%2C300&ssl=1)
Two Lung Carcinoid Survivors Inspire and Lead the Way
Deirdre Durant finished folding the last of 1,000 origami cranes only days before surgery to remove her left lung. She was seeking to fulfill the ancient Japanese legend that promises anyone who folds a thousand origami cranes will be granted a wish by…
READ MORE![Carcinoid Car, Sponsafier 4](https://i0.wp.com/www.carcinoid.org/wp-content/uploads/2011/08/carcinoid-car-sponsafier-4.jpg?resize=300%2C300&ssl=1)
Racing for a Cause: Please Vote for the Carcinoid Car through August 20
UPDATE, August 22: Voting is now closed for the Carcinoid Car. Thanks to all who voted the Carcinoid Car received 2,114 votes!! If the car goes to Round Two we will share the information with everyone and ask for your votes again. We really appreciate…
READ MORE![Toby Plank and Family](https://i0.wp.com/www.carcinoid.org/wp-content/uploads/2011/08/toby-plank-and-family.jpg?resize=300%2C300&ssl=1)
Colorado Golf Tournament to Benefit Carcinoid Cancer Foundation and High School Scholarship Fund
If you love golf, want to support the Carcinoid Cancer Foundation, and are in the Denver, Colorado, area on Saturday, September 24, 2011, please sign up for The Toby Plank Memorial Golf Tournament. The tournament will be held in memory of Toby M. Plank, …
READ MORE![zebra whimsical pin pendant1](https://i0.wp.com/www.carcinoid.org/wp-content/uploads/2011/07/zebra-whimsical-pin_pendant1.jpg?resize=300%2C300&ssl=1)
New Zebra Jewelry Signature Line Available at The Barking Zebra
Suzi Garber, jewelry designer and owner of The Barking Zebra website, www.barkingzebra.net, has added a Signature Line of zebra pins, earrings, cufflinks, and charms to the collection of elegant awareness jewelry available on her website. The jewelry…
READ MORE![clincial trials logo](https://i0.wp.com/www.carcinoid.org/wp-content/uploads/2011/07/clincial-trials-logo.gif?resize=300%2C54&ssl=1)
Phase II Clinical Trial Recruiting Carcinoid and Related Neuroendocrine Tumor Patients
Participants are being recruited for a Phase II clinical study of capecitabine and temozolomide (CAPTEM) for neuroendocrine cancer patients with progressive, differentiated, metastatic neuroendocrine tumors (NETs). Patients with carcinoid,…
READ MORE![CCAN logo](https://i0.wp.com/www.carcinoid.org/wp-content/uploads/2011/07/ccan-logo.jpg?resize=300%2C281&ssl=1)
9 Conferences for the Carcinoid and Neuroendocrine Tumor Community
If you are a carcinoid or NET cancer survivor, caregiver, family member or medical professional you can learn about what’s happening now and what’s new in carcinoid/NETs treatments, clinical trials, research, and more from specialists…
READ MORE